Tag: Diabetes: Drugs
Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality
Metformin Recalled Due to Potential Cancer-Causing Chemical
Recall is for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex
FDA: Insulin Among Drugs Transitioned to Biological Products
New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Findings seen in propensity-matched cohorts versus receipt of DPP-4 inhibitors or GLP-1 agonists
Metformin May Cut Mortality Risk in Post-Pancreatitis Diabetes
Survival benefit not seen with ever use of metformin for pancreatic cancer-related diabetes
Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
Cardiovascular risk increased with sulfonylureas and basal insulin versus newer classes of ADM
DPP-4I Not Tied to Increased Risk of Acute Pancreatitis in Seniors
Among adults with heart disease, risk increased with DPP-4I versus thiazolidinedione not sulfonylureas
Exposure to Metformin In Utero Ups Risk of Being Overweight
Findings among children of women with polycystic ovary syndrome on metformin during pregnancy
No Link Found for Metformin or Statins and Ovarian Cancer
Findings based on a Finnish study involving a national cohort of women with type 2 diabetes
Bariatric Surgery Linked to Discontinuing Diabetes Meds
Six-year antidiabetes treatment initiation rate also much lower after bariatric surgery
